Quinoxalines Versus Indolinones as Inhibitors of Restenosis
نویسندگان
چکیده
منابع مشابه
Quinoxalines versus indolinones as inhibitors of restenosis.
of Restenosis To the Editor: We would like to point out several issues related to citations of the scientific literature in an article by Yamasaki et al.1 We would like to emphasize that quinoxalines were the first compounds showing excellent efficacy in inhibiting balloon injury–induced stenosis in pigs and rats. Reference 20 in the article by Yamasaki et al, which describes this study, is not...
متن کاملVessel restenosis versus "streamlining".
Restenosis secondary to intimal hyperplasia within small diameter intravascular stents is a major problem in the adult population with atherosclerotic vascular disease. In contrast, most large series of stent implants in congenital lesions suggest that restenosis is rarely a problem. Schneider and colleagues, in this issue of Heart, point out that paediatric patients grow and that stents implan...
متن کاملRibonucleotide Reductase Inhibitors for Restenosis
Percutaneous transluminal coronary angioplasty (PTCA) has greatly benefited patients with occluded coronary arteries, but its benefits have been undermined by a high incidence of restenosis. The introduction of coronary stents has significantly improved the short and long term outcome but restenosis still occurs in approximately 15-30 % of patients within 6 months. Research efforts are now bein...
متن کاملPDGF receptor kinase inhibitors for the treatment of restenosis.
The clogging of arteries by neointima is a hallmark of atherosclerosis and of restenosis following balloon angioplasty. The realization in the 1980s that PDGF and its receptor play a key role in the onset of neointimal formation led us to develop PDGFR kinase inhibitors as antirestenosis agents. In this review, we describe the development of these inhibitors and their implementation as antirest...
متن کاملAromatase inhibitors versus antioestrogens
Endocrine therapies act by either blocking or downregulating the oestrogen receptor or by reducing oestrogen concentrations around and within the cancer cell. In postmenopausal women, oestrogen suppression is achieved by inhibition of the enzyme aromatase by aromatase inhibitors (AIs). Modern AIs (anastrozole, letrozole and exemestane) are more potent than earlier ones and suppress oestradiol l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation Research
سال: 2001
ISSN: 0009-7330,1524-4571
DOI: 10.1161/hh1101.092522